Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Peter van Swieten"'
Autor:
Marjon Navis, Diana Edo Matas, Andrea Rachinger, Fransje A Koning, Peter van Swieten, Neeltje A Kootstra, Hanneke Schuitemaker
Publikováno v:
PLoS ONE, Vol 3, Iss 6, p e2422 (2008)
BACKGROUND: To address evolution of HIV-1 after transmission, we studied sequence dynamics in and outside predicted epitopes of cytotoxic T lymphocytes (CTL) in subtype B HIV-1 variants that were isolated from 5 therapy-naive horizontal HLA-disparate
Externí odkaz:
https://doaj.org/article/26f4b54125da42c4b1dffb2f159e79a0
Autor:
Mirjam de Waal, Hans L. Zaaijer, Michel Molier, Marijke W.A. Molenaar-de Backer, Thijs J W van de Laar, Boris M. Hogema, Margret Sjerps, Peter van Swieten
Publikováno v:
Transfusion. 56:722-728
BACKGROUND The incidence of hepatitis E virus (HEV) infection in the Netherlands is high. Blood donors are not routinely screened for HEV infection, but since January 2013, donations used for the production of solvent/detergent (S/D)-treated plasma h
Autor:
Peter van Swieten, Hans L. Zaaijer, Véronique A. Van Gaever, Veerle Compernolle, An Muylaert, Thijs J W van de Laar
Publikováno v:
Virology, 515, 243-249. Academic Press Inc.
During 2006-2016, hepatitis B virus (HBV) was detected in nearly 400 blood donors in the Netherlands and Flanders. Donor demographics and self-reported risk factors as disclosed during the donor exit interview were compared to HBV phylogenies of dono
Autor:
Boris M, Hogema, Michel, Molier, Margret, Sjerps, Mirjam, de Waal, Peter, van Swieten, Thijs, van de Laar, Marijke, Molenaar-de Backer, Hans L, Zaaijer
Publikováno v:
Transfusion. 56(3)
The incidence of hepatitis E virus (HEV) infection in the Netherlands is high. Blood donors are not routinely screened for HEV infection, but since January 2013, donations used for the production of solvent/detergent (S/D)-treated plasma have been sc
Autor:
José A. M. Borghans, Hanneke Schuitemaker, Ingrid M. M. Schellens, Neeltje A. Kootstra, Peter van Swieten, Debbie van Baarle, Marjon Navis, Frank Miedema
Publikováno v:
Journal of infectious diseases, 197(6), 871-879. Oxford University Press
Journal of Infectious Diseases, 197(6), 871. Oxford University Press
Journal of Infectious Diseases, 197(6), 871. Oxford University Press
The human leukocyte antigen (HLA) B57 allele and the closely related HLA-B5801 allele are overrepresented among human immunodeficiency virus type 1 (HIV-1)-infected individuals with a long-term nonprogressive clinical course of disease (known as "lon
Publikováno v:
Journal of Allergy and Clinical Immunology. 86:107-116
In this study, we investigated the cross-reactivity pattern of IgE and IgG4 antibodies to the major feline allergen, Fel d I. We studied the IgE and IgG4 response of 11 cat-allergic patients against Fel d I-like structures in eight members of the Fel
Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection
Autor:
Peter van Swieten, Frank Miedema, José Borghans, Ingrid M. M. Schellens, Hanneke Schuitemaker, Marjon Navis, Neeltje A. Kootstra, Debbie van Baarle
Publikováno v:
Journal of Immunology, 179(5), 3133. American Association of Immunologists
Journal of immunology (Baltimore, Md., 179(5), 3133-3143. American Association of Immunologists
Journal of immunology (Baltimore, Md., 179(5), 3133-3143. American Association of Immunologists
HLA B57 and the closely related HLA B5801 are over-represented among HIV-1 infected long-term nonprogressors (LTNPs). It has been suggested that this association between HLA B57/5801 and asymptomatic survival is a consequence of strong CTL responses
Autor:
Peter van Swieten, Frank van Leth, Jan M. Prins, Sanjay U. C. Sankatsing, Marion Cornelissen, Frank Miedema, Suzanne Jurriaans, Joep M. A. Lange, Hanneke Schuitemaker
Publikováno v:
AIDS (London, England), 18(14), 1925-1931. Lippincott Williams and Wilkins
Objective: To study the effect of mycophenolate mofetil (MMF) on the decay rate of plasma HIV-1 RNA and the latently infected cellular reservoir in treatment-naive patients starting antiretroviral therapy. Design: Randomized trial. Methods: A group o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da65629733903b709cfe1856b5e1fa6
https://pure.amc.nl/en/publications/highly-active-antiretroviral-therapy-with-or-without-mycophenolate-mofetil-in-treatmentnaive-hiv1-patients(3a59b54e-e56b-4f8a-a419-5e8a8c0e4ff1).html
https://pure.amc.nl/en/publications/highly-active-antiretroviral-therapy-with-or-without-mycophenolate-mofetil-in-treatmentnaive-hiv1-patients(3a59b54e-e56b-4f8a-a419-5e8a8c0e4ff1).html
Publikováno v:
Journal of Allergy and Clinical Immunology. 87:327